Qube Research & Technologies (QRT)
BIOL

Qube Research & Technologies (QRT)’s Biolase, Inc. BIOL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,000
Closed -$759 – 4925
2024
Q1 		$759 Buy
+4,000
New +$1.95K ﹤0.01% 4059

Other funds holding BIOL

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BIOL Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 4,000 shares — an estimated $759 sold.

Qube Research & Technologies (QRT) first reported a position in BIOL in Q1 2024 and held it in 1 quarter. The position peaked at $759 in Q1 2024. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 4,000 Biolase, Inc. shares in Q2 2024, an estimated $759.
  • Qube Research & Technologies (QRT) first reported a position in Biolase, Inc. in Q1 2024 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Biolase, Inc. position peaked at $759 in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.